Collectively, the top eight blockbuster drugs of 2024 generated over $116 billion in sales last year. Looking closer at these figures provides insight into the shifting landscape of the pharmaceutical ...

Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...

In people with a life-threatening clot and no identification of what caused it, or if something caused it that can't be fixed ...

Although new U.S. tariffs on Canada, Mexico, and China are putting pressure on markets, investors are shifting toward ...

The expected out-of-pocket costs for commonly used drugs like Eliquis and Ozempic have surged for Medicare beneficiaries in stand-alone drug plans in recent years.

Welcome to Medicare Part D, where your prescription drugs come with co-pays and co-insurance. If you thought co-pays and ...

For this understudied population, the findings may offer some reassurance as apixaban is already the most prescribed OAC in ...

A. Eliquis (apixaban) is a lifesaving anticoagulant that reduces the risk of blood clots that could cause a stroke. The price in the U.S. is more than $600 for a month’s supply. That’s with a coupon ...

but I just can’t afford the big three – the Eliquis, Jardiance and Tikosyn, and unfortunately, a lot of programs are income-based and I make too much to qualify but not enough to afford (the drugs).

The blood thinner Eliquis was Bristol Myers Squibb’s highest revenue-generating medication last year. It was also one of the 10 drugs that were subject to Medicare price negotiations under the ...